Pelthos Therapeutics Inc.
PTHS- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001919246
In the last 90 days, Pelthos Therapeutics Inc. insiders filed 0 open-market purchases and 3 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $37.4M in total; no superinvestor holds it.
Holders of 5% or more of PTHS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Pelthos Therapeutics Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Ligand Pharmaceuticals Inc | 13D/A | 49.90%5.19M shares | 0.00 ppfrom 49.90% | Jul 3, 20252 filings | Nov 10, 2025 | SEC |
| 3i, LP | 13G | 9.90%303.1K shares | New | Jul 8, 20251 filing | Jul 8, 2025 | SEC |
| Alexandra Wood (Canada) Inc. | 13G | 9.53%574.2K shares | New | Jan 15, 20251 filing | Jan 15, 2025 | SEC |
| Murchinson Ltd. | 13G | 9.10%280.0K shares | New | Nov 14, 20251 filing | Nov 14, 2025 | SEC |
| Friedberg Ezra M | 13D/A | 8.30%250.1K shares | – | Jul 3, 20251 filing | Jul 3, 2025 | SEC |
| Ikarian Capital, LLC | 13G | 7.30%440.8K shares | New | Feb 14, 20251 filing | Feb 14, 2025 | SEC |
| Ikarian Capital, LLC | 13G/A | 6.10%186.4K shares | – | Nov 14, 20251 filing | Nov 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on Pelthos Therapeutics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 20256:33 PM ET | Ikarian Capital, LLCand 1 other | 13G/A | 6.10%186.4K shares | – | Sep 30, 2025 | SEC |
| Nov 14, 20251:52 PM ET | Murchinson Ltd.and 1 other | 13G | 9.10%280.0K shares | New | Sep 30, 2025 | SEC |
| Nov 10, 20254:42 PM ET | Ligand Pharmaceuticals Inc | 13D/A | 49.90%5.19M shares | 0.00 ppfrom 49.90% | Nov 6, 2025 | SEC |
| Aug 13, 20256:24 PM ET | AME Equities LLCand 1 other | 13G/A | 0.00%0 shares | –Below 5% | Jun 30, 2025 | SEC |
| Jul 8, 20254:05 PM ET | 3i, LPand 2 others | 13G | 9.90%303.1K shares | New | Jul 1, 2025 | SEC |
| Jul 3, 20259:07 PM ET | Friedberg Ezra Mand 2 others | 13D/A | 8.30%250.1K shares | – | Jul 1, 2025 | SEC |
| Jul 3, 20254:05 PM ET | Ligand Pharmaceuticals Inc | 13D | 49.90%4.93M shares | New | Jul 1, 2025 | SEC |
| Feb 14, 20251:09 PM ET | Ikarian Capital, LLCand 1 other | 13G | 7.30%440.8K shares | New | Dec 31, 2024 | SEC |
| Jan 15, 20255:27 PM ET | Alexandra Wood (Canada) Inc. | 13G | 9.53%574.2K shares | New | Dec 13, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Pelthos Therapeutics Inc. shares.
No Form 144 notices for Pelthos Therapeutics Inc. are on file.